TRVI
Trevi Therapeutics, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Neutral
-7/100
Last price
13.20
▼ 0.52 (3.79%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
13.20
Prev close
13.72
Day high
13.83
Day low
13.00
Volume
5.00M
Market cap
$1.88B
P/E (TTM)
—
52W range
9.28 – 20.22
Day trading desk
Gap from prior close
-3.79%
Prior close 13.72
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
13.20 – 13.20
Position in range
—
—
ATR (14D)
0.61
4.59% of price
Prior day high
14.11
PDH
Prior day low
13.51
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 1.92M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-8.60%
-10.5%
1M
-23.64%
-24.8%
3M
-29.10%
-33.6%
6M
+0.61%
-17.6%
YTD
+5.27%
-9.0%
1Y
+33.40%
+17.0%
3Y
+504.59%
+422.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on TRVI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
1
39.47K shares
Sell transactions
1
39.47K shares
Net transactions
+2
Buys less sells
Sell : buy shares
1.0 : 1
Mixed
Insider-held shares
894.75K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 15, 26 | HEFFERNAN MICHAEL THOMAS Director |
SELL | 39.47K | $595.81K | Direct |
| Sep 15, 26 | HEFFERNAN MICHAEL THOMAS Director |
CONVERSION | 39.47K | $126.10K | Direct |
| Dec 2, 25 | GALLETTA CHRISTOPHER Officer |
CONVERSION | 4.22K | $2.16K | Direct |
| Apr 17, 25 | BASKETT FOREST Beneficial Owner of more than 10% of a Class of Security |
CONVERSION | 1.85M | $2.54M | Indirect |
| Apr 17, 25 | WALKER PAUL EDWARD Beneficial Owner of more than 10% of a Class of Security |
CONVERSION | 1.85M | $2.54M | Indirect |
| Apr 17, 25 | FLORENCE ANTHONY A JR Beneficial Owner of more than 10% of a Class of Security |
CONVERSION | 1.85M | $2.54M | Indirect |
| Apr 17, 25 | BEHBAHANI ALI Beneficial Owner of more than 10% of a Class of Security |
CONVERSION | 1.85M | $2.54M | Indirect |
| Apr 17, 25 | MAKHZOUMI MOHAMAD Beneficial Owner of more than 10% of a Class of Security |
CONVERSION | 1.85M | $2.54M | Indirect |
| Apr 17, 25 | NEW ENTERPRISE ASSOCIATES 16, L.P. Beneficial Owner of more than 10% of a Class of Security |
CONVERSION | 1.85M | $2.54M | Indirect |
| Apr 17, 25 | CHANG CARMEN Beneficial Owner of more than 10% of a Class of Security |
CONVERSION | 1.85M | $2.54M | Indirect |
| Apr 17, 25 | SANDELL SCOTT D Beneficial Owner of more than 10% of a Class of Security |
CONVERSION | 1.85M | $2.54M | Indirect |
| Mar 25, 25 | SCIASCIA THOMAS R Officer |
SELL | 2.63K | $17.36K | Direct |
| Mar 25, 25 | SCIASCIA THOMAS R Officer |
CONVERSION | 2.63K | $3.76K | Direct |
| Mar 21, 25 | GOOD JENNIFER L Chief Executive Officer |
SELL | 5.26K | $34.63K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BASKETT FOREST |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
BEHBAHANI ALI |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
CHANG CARMEN |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
FLORENCE ANTHONY A JR |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
GOOD JENNIFER L |
Chief Executive Officer | 213.31K | Sale |
MAKHZOUMI MOHAMAD |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
NEW ENTERPRISE ASSOCIATES 16, L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
SANDELL SCOTT D |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
SCIASCIA THOMAS R |
Officer | 221.37K | Sale |
WALKER PAUL EDWARD |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
Fundamentals
Market cap$1.88B
Enterprise value$1.56B
Revenue (TTM)—
Gross profit—
EBITDA$-59.42M
Net income$-51.11M
EPS (TTM)$-0.35
Free cash flow$-33.28M
Total cash$318.87M
Total debt$605.00K
Book value / share$2.26
Shares outstanding142.48M
Float118.32M
Short % of float9.40%
Dividend yield0.00%
Beta (5Y)0.98
Valuation & profitability ratios
Trailing P/E—
Forward P/E-22.84
PEG ratio—
Price / sales—
Price / book5.84
EV / revenue—
EV / EBITDA-26.25
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-19.66%
Return on assets-13.82%
Debt / equity0.19
Current ratio37.28
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $33.48M | $39.38M | $23.68M | $19.83M | -15.0% |
| Selling, general & admin | $15.85M | $12.15M | $10.24M | $10.07M | +30.5% |
| Total operating expense | $49.33M | $51.52M | $33.92M | $29.91M | -4.3% |
| Operating income | -$49.33M | -$51.52M | -$33.92M | -$29.91M | +4.3% |
| Net interest income | $6.54M | $3.60M | $4.36M | $577.00K | +81.7% |
| Pre-tax income | -$42.82M | -$47.94M | -$29.10M | -$29.19M | +10.7% |
| Tax provision | -$64.00K | -$30.00K | -$32.00K | -$36.00K | -113.3% |
| Net income | -$42.76M | -$47.91M | -$29.07M | -$29.15M | +10.8% |
| Net income to common | -$42.76M | -$47.91M | -$29.07M | -$29.15M | +10.8% |
| Basic EPS | -0.32 | -0.47 | -0.29 | -0.45 | +31.9% |
| Diluted EPS | -0.32 | -0.47 | -0.29 | -0.45 | +31.9% |
| EBIT | -$42.82M | -$47.94M | -$28.71M | -$28.02M | +10.7% |
| EBITDA | -$42.68M | -$47.79M | -$28.58M | -$27.98M | +10.7% |
| Basic shares | 134.75M | 101.97M | 99.03M | 64.54M | +32.1% |
| Diluted shares | 134.75M | 101.97M | 99.03M | 64.54M | +32.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $18.91M | $34.10M | $32.40M | $12.59M | — | -44.5% |
| Cash & short-term investments | $188.26M | $107.62M | $82.97M | $120.51M | — | +74.9% |
| Total current assets | $191.66M | $109.43M | $87.55M | $122.62M | — | +75.1% |
| Property, plant & equipment | $855.00K | $1.23M | $1.56M | $194.00K | — | -30.4% |
| Total assets | $193.44M | $110.90M | $89.40M | $123.02M | — | +74.4% |
| Total current liabilities | $9.75M | $10.51M | $5.82M | $13.40M | — | -7.2% |
| Current debt | — | — | — | $7.00M | $5.83M | — |
| Long-term debt | — | — | — | $2.15M | $8.65M | — |
| Total debt | $753.00K | $1.03M | $1.34M | $9.18M | — | -27.0% |
| Total liabilities | $10.20M | $11.26M | $6.86M | $15.56M | — | -9.4% |
| Retained earnings | -$329.80M | -$287.05M | -$239.13M | -$210.07M | — | -14.9% |
| Shareholder equity | $183.24M | $99.64M | $82.55M | $107.46M | — | +83.9% |
| Working capital | $181.91M | $98.92M | $81.72M | $109.22M | — | +83.9% |
| Net tangible assets | $183.24M | $99.64M | $82.55M | $107.46M | — | +83.9% |
| Shares issued | 128.31M | 93.60M | 68.28M | 59.94M | — | +37.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$42.76M | -$47.91M | -$29.07M | -$29.15M | +10.8% |
| Depreciation & amortisation | $144.00K | $147.00K | $123.00K | $43.00K | -2.0% |
| Stock-based compensation | $5.18M | $3.59M | $2.25M | $2.33M | +44.5% |
| Change in working capital | -$3.49M | $6.83M | -$3.85M | -$1.23M | -151.1% |
| Operating cash flow | -$42.09M | -$38.26M | -$31.71M | -$28.18M | -10.0% |
| Capital expenditure | -$12.00K | -$35.00K | -$137.00K | -$159.00K | +65.7% |
| Investing cash flow | -$94.11M | -$21.53M | $59.43M | -$107.37M | -337.1% |
| Financing cash flow | $121.01M | $61.48M | -$7.91M | $111.31M | +96.8% |
| Free cash flow | -$42.10M | -$38.29M | -$31.85M | -$28.33M | -10.0% |
| End cash position | $18.91M | $34.10M | $32.40M | $12.59M | -44.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — |
| Research & development | $15.15M | $9.94M | $6.19M | $10.09M | $9.39M | +52.4% |
| Selling, general & admin | $5.36M | $4.97M | $4.03M | $3.83M | $4.33M | +7.8% |
| Total operating expense | $20.51M | $14.91M | $10.22M | $13.92M | $13.72M | +37.5% |
| Operating income | -$20.51M | -$14.91M | -$10.22M | -$13.92M | -$13.72M | -37.5% |
| Net interest income | $2.70M | $1.70M | $1.90M | $2.10M | $1.41M | +59.0% |
| Pre-tax income | -$17.82M | -$13.21M | -$8.33M | -$11.82M | -$12.32M | -34.8% |
| Tax provision | -$19.00K | -$20.00K | -$16.00K | -$15.00K | -$21.00K | +5.0% |
| Net income | -$17.80M | -$13.19M | -$8.32M | -$11.80M | -$12.30M | -34.9% |
| Net income to common | -$17.80M | -$13.19M | -$8.32M | -$11.80M | -$12.30M | -34.9% |
| Basic EPS | -0.11 | -0.09 | -0.06 | -0.08 | -0.09 | -22.2% |
| Diluted EPS | -0.11 | -0.09 | -0.06 | -0.08 | -0.09 | -22.2% |
| EBIT | -$20.51M | -$14.91M | -$8.33M | -$11.82M | -$13.72M | -37.5% |
| EBITDA | -$20.48M | -$14.88M | -$8.30M | -$11.78M | -$13.68M | -37.6% |
| Basic shares | 156.60M | 145.59M | 145.50M | 145.10M | 130.35M | +7.6% |
| Diluted shares | 156.60M | 145.59M | 145.50M | 145.10M | 130.35M | +7.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $54.30M | $19.41M | $18.91M | $56.87M | $117.06M | +179.7% |
| Cash & short-term investments | $318.87M | $171.78M | $188.26M | $194.93M | $203.88M | +85.6% |
| Total current assets | $325.70M | $176.12M | $191.66M | $198.30M | $207.23M | +84.9% |
| Property, plant & equipment | $878.00K | $875.00K | $855.00K | $954.00K | $1.04M | +0.3% |
| Total assets | $330.52M | $179.61M | $193.44M | $199.36M | $208.34M | +84.0% |
| Total current liabilities | $8.74M | $7.12M | $9.75M | $9.04M | $9.24M | +22.8% |
| Total debt | $605.00K | $682.00K | $753.00K | $823.00K | $891.00K | -11.3% |
| Total liabilities | $9.01M | $7.48M | $10.20M | $9.57M | $9.85M | +20.5% |
| Retained earnings | -$360.79M | -$343.00M | -$329.80M | -$321.49M | -$309.69M | -5.2% |
| Shareholder equity | $321.51M | $172.13M | $183.24M | $189.79M | $198.49M | +86.8% |
| Working capital | $316.97M | $169.01M | $181.91M | $189.26M | $197.99M | +87.5% |
| Net tangible assets | $321.51M | $172.13M | $183.24M | $189.79M | $198.49M | +86.8% |
| Shares issued | 141.98M | 128.41M | 128.31M | 128.22M | 121.78M | +10.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$17.80M | -$13.19M | -$8.32M | -$11.80M | -$12.30M | -34.9% |
| Depreciation & amortisation | $34.00K | $34.00K | $31.00K | $38.00K | $38.00K | 0.0% |
| Stock-based compensation | $3.27M | $2.19M | $1.35M | $1.24M | $1.38M | +49.3% |
| Change in working capital | -$2.52M | -$5.40M | -$274.00K | -$169.00K | $1.05M | +53.2% |
| Operating cash flow | -$17.43M | -$16.69M | -$7.63M | -$10.88M | -$10.10M | -4.4% |
| Capital expenditure | -$124.00K | -$102.00K | — | — | — | -21.6% |
| Investing cash flow | -$112.04M | $16.96M | -$30.61M | -$50.94M | -$2.61M | -760.4% |
| Financing cash flow | $164.36M | $222.00K | $284.00K | $1.63M | $110.39M | +73,934.7% |
| Free cash flow | -$17.55M | -$16.79M | -$7.63M | -$10.89M | -$10.10M | -4.5% |
| End cash position | $54.30M | $19.41M | $18.91M | $56.87M | $117.06M | +179.7% |
Options analytics
Put / call volume
0.11
Call-heavy session
Put / call open interest
0.10
Positioning, not flow
Max pain
14.00
+6.2% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
+294.1%
Puts bid over calls
Call volume
2.56K
Contracts, this expiry
Put volume
293
Contracts, this expiry
Heaviest call OI
17.00
2.52K contracts
Heaviest put OI
15.00
596 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.11 | -0.11 | -0.9% |
| Mar 2026 | -0.07 | -0.09 | -23.3% |
| Dec 2025 | -0.10 | -0.06 | +37.2% |
| Sep 2025 | -0.10 | -0.08 | +19.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.13 | 10 | $0 | 0.0% |
| Next quarter | -0.14 | 10 | $0 | 0.0% |
| Current year | -0.48 | 10 | $0 | 0.0% |
| Next year | -0.58 | 10 | $0 | 0.0% |
Analyst targets & ownership
Mean target$28.18
High target$40.00
Low target$23.00
Implied upside113.50%
Analyst count11
ConsensusSTRONG BUY
Strong buy / Buy2 / 8
Hold0
Sell / Strong sell0 / 0
Held by insiders0.63%
Held by institutions107.74%
Institutions holding284
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
14.17
-6.83% from price
SMA 20
14.82
-11.05% from price
SMA 50
16.68
-21.00% from price
SMA 100
16.38
-19.40% from price
SMA 200
14.28
-7.68% from price
EMA 12
14.29
-7.66% from price
EMA 26
15.15
-12.88% from price
EMA 50
15.86
-16.80% from price
RSI (14)
21.1
Oversold
MACD (12,26,9)
-0.86
Hist -0.07
ATR (14)
0.61
4.60% of price
Realised vol 30D
35.3%
Annualised
Bollinger upper
16.45
20, 2σ
Bollinger lower
13.19
20, 2σ
50 / 200 cross
Golden
16.68 vs 14.28
Trend bias
Below 200
-7.68%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.04
More volatile than market
Correlation to SPY
0.24
Largely independent
Realised vol 30D
35.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-32.4%
Peak to trough
Max drawdown 5Y
-75.1%
Peak to trough
ATR 14
0.61
4.60% of price
Beta (reported)
0.98
5Y monthly, from filing
Short interest
Shares short
12.07M
Prior 12.66M
Change vs prior
-4.6%
Shorts covering
% of float
9.40%
Normal
% of shares out
8.47%
Against total outstanding
Days to cover
8.3
Crowded exit
Float
118.32M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 14, 26 | Jones Trading | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Aug 7, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Jul 21, 26 | BMO Capital | INITIATED | Outperform | Outperform |
| Jul 20, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Jul 20, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 20, 26 | Needham | MAINTAINED | Buy | Buy |
| May 6, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 6, 26 | Needham | MAINTAINED | Buy | Buy |
| Apr 17, 26 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Mar 19, 26 | Jones Trading | MAINTAINED | Buy | Buy |
| Mar 18, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-06-04
Periodic Financial Reports
10-Q · 2026-05-05
Annual Report to Shareholders
ARS · 2026-04-21
Corporate Changes & Voting Matters
8-K · 2026-04-17
Proxy Statements
PRE 14A · 2026-04-10
Corporate Changes & Voting Matters
8-K · 2026-03-17
Corporate Changes & Voting Matters
8-K · 2026-03-09
Headlines
Trevi Therapeutics' Sample Size Re-estimation for Chronic Cough Trial Likely Positive, Oppenheimer Says
MT Newswires · 12d ago
Trevi Therapeutics Insider Sold Shares Worth $595,806, According to a Recent SEC Filing
MT Newswires · 20d ago
Trevi Therapeutics (TRVI) Stock Trades At A Premium To Fair Value
Simply Wall St. · 32d ago
Trevi Therapeutics to Participate in Upcoming September Conferences
GlobeNewswire · 34d ago
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
GlobeNewswire · 42d ago
Trevi Therapeutics Q2 Earnings Call Highlights
MarketBeat · 61d ago
Oppenheimer Adjusts Trevi Therapeutics PT to $25 From $24, Maintains Outperform Rating
MT Newswires · 61d ago
Trevi Therapeutics Inc (TRVI) (Q2 2026) Earnings Call Highlights: Advancing Phase 3 Pipeline ...
GuruFocus.com · 61d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.